About Supreem Pharmaceuticals Mysore Private Limited
Data last updated: 10 January 2026
Supreem Pharmaceuticals Mysore Private Limited is a private limited company based in Nanjangudu, Karnataka, India. It specialises in preventive health supplements, a part of the broader healthcare sector. Incorporated on 16 August 1996, the company has been in operation for over 30 years.
Registered with ROC Bangalore under CIN U24231KA1996PTC020988.
Capital: an authorised share capital of ₹5.5 Cr and a paid-up capital of ₹3.94 Cr. Formerly known as Candor Laboratories Limited and Candor Labs Private Limited. It is led by directors including Geetha Sadananda Nagaraja Rao and Aditya Sadanand Rao.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: # 73 74 & 48P1 Kiadb Industrial Area, Nanjangudu, Karnataka, India – 571302.
As per the financials filed for FY 2025, the company reported a revenue of ₹82.17 Cr, a growth of 21% compared to the previous year.
The company has a workforce of approximately 207 employees as per the latest available data.
The company is associated with 1 brand - Supreem Pharmaceuticals. As per MCA filings, the company has open charges of ₹44.24 Cr and satisfied charges of ₹6.7 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website supreempharma.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered Address# 73 74 & 48P1 Kiadb Industrial Area, Nanjangudu, Karnataka, India – 571302
-
IndustryHealthcare, Preventive Health Supplements, Ayurvedic Products & Services
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Supreem Pharmaceuticals Mysore Private Limited
Supreem Pharmaceuticals Mysore Private Limited has undergone 2 name changes throughout its history. The company was previously known as Candor Laboratories Limited, and Candor Labs Private Limited.. The current legal name is Supreem Pharmaceuticals Mysore Private Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Supreem Pharmaceuticals Mysore Private Limited | Current |
| Candor Laboratories Limited | Previous |
| Candor Labs Private Limited. | Previous |
CIN History of Supreem Pharmaceuticals Mysore Private Limited
Supreem Pharmaceuticals Mysore Private Limited has one previous CIN (Corporate Identification Number): U24231KA1996PLC020988. The current CIN is U24231KA1996PTC020988, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231KA1996PTC020988 | Current |
| U24231KA1996PLC020988 | Previous |
Associated Brands with Supreem Pharmaceuticals Mysore Private Limited
Supreem Pharmaceuticals Mysore Private Limited operates one associated brand: Supreem Pharmaceuticals. These brands represent Supreem Pharmaceuticals Mysore Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufactures stabilized vitamins, minerals, and herbal extracts for food, pharma, and beauty sectors. | supreempharma.in |
Competitors & Alternatives of Supreem Pharmaceuticals Mysore Private Limited
Brands and companies operating in the same space as Supreem Pharmaceuticals Mysore Private Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Laurus Labs
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
Symbiotec
|
Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India, India | 2002 |
Beijing Biostar Technologies
|
APIs, intermediates, and biochemical reagents are developed and manufactured. | Beijing, China, China | 2002 |
Sterling Pharma Solutions
|
Contract development, manufacturing, and analytical services for APIs are offered. | Dudley, United Kingdom, United Kingdom | 2016 |
Provepharm Life Solutions
|
APIs and drug products are developed and valorized in pharmaceuticals. | Marseille, France, France | 1998 |
Hikal
|
APIs and intermediates are produced via custom synthesis and research. | Mumbai, India, India | 1988 |
Snapdragon Chemistry
|
Drug discovery and development service provider | Cambridge, United States, United States | 2014 |
SeQuent
|
APIs are developed and manufactured for therapeutic areas. | Bengaluru, India, India | 2002 |
Jubilant Pharma
|
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | Noida, India, India | 1978 |
Business Activity of Supreem Pharmaceuticals Mysore Private Limited
Supreem Pharmaceuticals Mysore Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Supreem Pharmaceuticals Mysore Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Supreem Pharmaceuticals Mysore Private Limited
Supreem Pharmaceuticals Mysore Private Limited is audited by PADIVAL AND ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PADIVAL AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history for Supreem Pharmaceuticals Mysore Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Supreem Pharmaceuticals Mysore Private Limited
Supreem Pharmaceuticals Mysore Private Limited is currently managed by 4 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Geetha Sadananda Nagaraja Rao
Also directs:
Supreem Pharmaceuticals Mysore Private Limited
|
Whole-Time Director | 22 Jan 2008 | 18 Years 6 Months | Current |
|
Aditya Sadanand Rao
Also directs:
Supreem Pharmaceuticals Mysore Private Limited
|
Whole-Time Director | 10 Jul 2020 | 6 Years 0 Months | Current |
|
Amit Sadanand Rao
Also directs:
Supreem Pharmaceuticals Mysore Private Limited
|
Whole-Time Director | 10 Jul 2020 | 6 Years 0 Months | Current |
|
Sadanand Nagaraja Rao
Also directs:
Supreem Pharmaceuticals Mysore Private Limited
|
Managing Director | 16 Aug 1996 | 29 Years 11 Months | Current |
Financials of Supreem Pharmaceuticals Mysore Private Limited FY 2025 filings available
Supreem Pharmaceuticals Mysore Private Limited reported revenue of ₹82.17 Cr (up 21.00% YoY) for FY 2025.
Ten-year financial statements for Supreem Pharmaceuticals Mysore Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Supreem Pharmaceuticals Mysore Private Limited
Shareholding and ownership data for Supreem Pharmaceuticals Mysore Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Supreem Pharmaceuticals Mysore Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jul 2023 | Axis Bank Limited | ₹5.94 Cr | Open |
| 09 Oct 2013 | Karnataka State Financial Corporation | ₹8.3 Cr | Open |
| 21 Nov 2007 | State Bank of India | ₹29.65 Cr | Open |
| 20 Sep 2002 | State Bank of India | ₹35.25 Lakh | Open |
| 04 Mar 2015 | Karnataka State Financial Corporation | ₹2 Cr | Satisfied |
Total charge records: 7 View all charges
Employees and EPFO Compliance at Supreem Pharmaceuticals Mysore Private Limited
Supreem Pharmaceuticals Mysore Private Limited has a workforce of 207 employees as of Apr 07, 2024.
Employee and EPFO history for Supreem Pharmaceuticals Mysore Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Supreem Pharmaceuticals Mysore Private Limited
GST registrations and filing compliance for Supreem Pharmaceuticals Mysore Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Supreem Pharmaceuticals Mysore Private Limited
Credit ratings, litigation, and regulatory alerts for Supreem Pharmaceuticals Mysore Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Supreem Pharmaceuticals Mysore Private Limited
MSME payment history for Supreem Pharmaceuticals Mysore Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Supreem Pharmaceuticals Mysore Private Limited
Corporate group structure for Supreem Pharmaceuticals Mysore Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Supreem Pharmaceuticals Mysore Private Limited
MCA filings and documents for Supreem Pharmaceuticals Mysore Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Supreem Pharmaceuticals Mysore Private Limited
Frequently Asked Questions about Supreem Pharmaceuticals Mysore Private Limited
Supreem Pharmaceuticals Mysore Private Limited is an active private limited company in the healthcare sector based in Nanjangudu, Karnataka, India. It was incorporated on 16 August 1996 (30+ years old) and is registered under CIN U24231KA1996PTC020988. The company has 207 employees.
Supreem Pharmaceuticals Mysore Private Limited reported revenue of ₹82.17 Cr for FY 2025 (up 21.00% YoY).
The current directors of Supreem Pharmaceuticals Mysore Private Limited are:
- Geetha Sadananda Nagaraja Rao - Whole-Time Director
- Aditya Sadanand Rao - Whole-Time Director
- Amit Sadanand Rao - Whole-Time Director
- Sadanand Nagaraja Rao - Managing Director
The primary industry of Supreem Pharmaceuticals Mysore Private Limited is healthcare. The company specifically operates in preventive health supplements. The company is currently active in this sector.
Supreem Pharmaceuticals Mysore Private Limited can be reached at the registered office: # 73 74 & 48P1 Kiadb Industrial Area, Nanjangudu, Karnataka, India – 571302, or through the website supreempharma.in.
The authorised capital is ₹5.5 Cr, and the paid-up capital is ₹3.94 Cr.